105.61 USD
↘ 4.86 (4.40%)AT CLOSE (11:59 AM EDT)
Inhibrx Biosciences, Inc. Common Stock
INBXNASDAQ • USD
105.70
↗ 0.09 (0.09%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
105.70
↗ 0.09 (0.09%)
Market: CLOSED
INBX is currently priced at $105.44. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (260.8%) and a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Sep 15, 2026.
Open?$109.44
High?$109.44
Low?$104.85
Prev. Close?$110.47
Volume?251.6K
Avg. Volume?325.1K
VWAP?$106.11
Rel. Volume?0.77x
Bid / Ask
Bid?$86.07 × 100
Ask?$143.64 × 100
Spread?$57.57
Midpoint?$114.85
Valuation & Ratios
Market Cap?1.6B
Shares Out?14.7M
Float?9.3M
Float %?63.3%
P/E Ratio?N/A
P/B Ratio?-30.69
EPS?-$9.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Themes
Employees
110
Market Cap
1.6B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?3
Momentum?23
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.01Distress
Confidence?68%Moderate
Short InterestSqueeze Risk
Short % of Float?35.49%Squeeze Risk
Short Interest?3.3M
Days to Cover?10.4
Free Float9.3M
Avg Daily Volume317.5K
Settlement Date2026-08-31
Financial Health
Current Ratio?5.07Strong
Quick Ratio?5.07Strong
Cash Ratio?4.75Strong
Debt/Equity?-3.33Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-30.69CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-13.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?260.8%STRONG▾
Peers50
S&P97
ROA?-89.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-131899000
Enterprise Value?$1.7B
Fundamentals ratios updated end of day